Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Retinoblastoma × Mass Screening × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Uterine Cervical Neoplasms 8 Breast Neoplasms 8 Neoplasms 7 Colorectal Neoplasms 7 Lung Neoplasms 4 Uterine Cervical Dysplasia 2 Prostatic Neoplasms 2 Papillomavirus Infections 2 Pancreatic Neoplasms 2 HIV Infections 2 Gastrointestinal Neoplasms 2 the Rate of Participation in Screening for PBC 1 Warts 1 Venous Thromboembolism 1 Uterine Cervical Diseases 1 Urinary Bladder Neoplasms 1 Tinea 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Retinoblastoma 1 Radiation Injuries 1 Pulmonary Atelectasis 1 Postural Orthostatic Tachycardia Syndrome 1 Postoperative Complications 1 Pneumonia 1 Pancreatic carcinoma, familial 1 Pancreatic cancer, adult 1 Oncology Problem 1 Nevus 1

Interventions

Carboplatin 19 Etoposide 17 Vincristine 13 Melphalan 10 Filgrastim 10 Granulocyte Colony-Stimulating Factor 9 Topotecan 8 Cyclophosphamide 8 Thiotepa 6 Mesna 4 Cryotherapy 4 Busulfan 4 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Ifosfamide 3 Drug Therapy 3 Doxorubicin 3 Watchful Waiting 2 Temozolomide 2 Magnetic Resonance Imaging 2 Eye Enucleation 2 Cisplatin 2 Brachytherapy 2 trioctyl phosphine oxide 1 sargramostim 1 racotumomab 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 omburtamab I-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06367569 2024-04-16

TRbFU

Amsterdam UMC, location VUmc

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡